PRRT2 and neoplasm: In contrast, the Akt/NICD/sgEGFP group exhibited many tumor nodules, thereby confirming that knockout of Mad2l1 can suppress iCCA growth and development in the Akt/NICD tumor model (Supplementary Fig. 7B).